MAIA Biotechnology

MAIANYSE United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$83.343 M

$1.37 +3.01%

Close of 22 Sept 2026

Revenue

$0.00

#3637 by revenue

Earnings

-$22.4M

Loss-making

Shares outstanding

60,825,844

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#319Gain TherapeuticsGANX$85.1M
#320Aldeyra TherapeuticsALDX$84.2M
#321MAIA BiotechnologyMAIA$83.3M
#322OS TherapiesOSTX$82.3M
#323Fortress BiotechFBIO$81.7M

Insiders buying

All insider buying →

2 open-market purchases by officers and directors of MAIA Biotechnology, worth $51.9K. Grants and option exercises are excluded.

Ramiro Guerrero$49.5K
37,595 shares at $1.32 on 10 Sept 2026 · filed 14 Sept 2026
Ramiro Guerrero$2.39K
1,794 shares at $1.33 on 24 Aug 2026 · filed 26 Aug 2026

What if MAIA Biotechnology were worth as much as…

Open the what-if tool →

Gold $30.2T

$496,989.63

Per share 362,766× higher

Bitcoin $1.74T

$28,629.54

Per share 20,897× higher

Nvidia $5.52T

$90,668.84

Per share 66,182× higher

Or at a round number

$200.0M $500.0M $1.00B $2.00B

Where these numbers come from

Share counts and financials for MAIA Biotechnology are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.